QAS. AI is a leading brand in the field of artificial intelligence and quantitative angiographic systems. They specialize in developing software integrated with image guided surgical equipment to optimize neurovascular treatments.

With a team of experts in biomedical engineering, neurosurgery, and pathology, QAS. AI focuses on improving diagnosis and treatment outcomes for patients affected by various vascular diseases. At the helm of QAS.

AI is Chief Executive Officer, Ciprian N Ionita, PhD, who brings over 20 years of experience in the medical imaging, healthcare, software, and technology industries. As an assistant professor at The University at Buffalo, he directs the Endovascular Devices and Imaging lab at the Canon Stroke and Vascular Research Center. His extensive research has led to the development of QAS.

AI's core technology. The brand also benefits from the expertise of Chief Medical Officer, Dr. Jason Davies, who holds an MD and PhD in Biophysics from Stanford.

Dr. Davies is an Assistant Professor of Neurosurgery and Biomedical Informatics at the State University of New York (SUNY) at Buffalo. His research focuses on advancing personalized medicine through the use of bioinformatics tools and machine learning.

With a strong commitment to innovation and patient care, QAS. AI is revolutionizing the field of neurovascular treatments through their cutting-edge technology and multidisciplinary approach